Home › Pulmonary Arterial Hypertension › Texas
Pulmonary Arterial Hypertension clinical trials in Texas
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Texas.
Cities in Texas
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- UT Southwestern Medical Center, Dallas
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07365332Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- UT Southwestern Medical Center, Dallas
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- PPD Development LP, Austin
- PPD Development LP, Austin
- UT Southwestern Medical Center, Dallas
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- UT Southwestern Medical Center, Dallas
- Texas Children's Hospital, Houston
- Baylor Scott & White, Plano
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Texas Children's, Houston
RecruitingObservational study
1 Day – 21 Years · All sexes · Updated Mar 13, 2025 · NCT02249923From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.